Skip to main content
Premium Trial:

Request an Annual Quote

Biocept, Cleared4 Partner to Provide COVID-19 Testing, Management Service

NEW YORK – Biocept said Wednesday that it has partnered with health validation firm Cleared4 to develop a system for tracking and managing COVID-19 testing requirements and test results for Biocept customers.

The new service uses Cleared4's health platform, allowing organizations that have contracted Biocept for COVID-19 testing to incorporate customized protocols and requirements for their individual situation. The platform will integrate results from Biocept's RT-PCR-based COVID-19 testing in real time, and administrators will be able to monitor the program and results for their organizations via a secure dashboard.

Financial terms of the deal were not disclosed.

Cleared4 describes its platform as a turnkey system that enables an individual's health status to be connected to any form of access control in real time, including venue apps or employer tools. It allows users to customize their own requirements for symptom checking, test results, and vaccination data to trigger access to a whole location or a specific zone within a location.

"As our customers strive to safely reopen or increase populations at campuses, businesses, healthcare facilities and other venues, there is an urgent need for a system to help streamline implementation of testing protocols and track COVID-19 testing results. Our goal is to help ease the administrative burden of complying with complex health requirements for our customers," Biocept CEO Michael Nall said in a statement.

Biocept's PCR-based COVID-19 testing launched last year as the pandemic expanded and has rapidly come to dwarf its core cancer liquid biopsy services. The company said it has received more than 400,000 samples for COVID-19 testing to date.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.